NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69315-163-50 | 69315-163 | HUMAN PRESCRIPTION DRUG | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE | ORAL | 20210415 | N/A | ANDA | ANDA211618 | Leading Pharma, LLC | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 50 CAPSULE in 1 PACKAGE (69315-163-50) |
69315-163-05 | 69315-163 | HUMAN PRESCRIPTION DRUG | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE | ORAL | 20210415 | N/A | ANDA | ANDA211618 | Leading Pharma, LLC | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 500 CAPSULE in 1 PACKAGE (69315-163-05) |
69315-163-01 | 69315-163 | HUMAN PRESCRIPTION DRUG | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE | ORAL | 20210415 | N/A | ANDA | ANDA211618 | Leading Pharma, LLC | DOXEPIN HYDROCHLORIDE | 150 mg/1 | 100 CAPSULE in 1 PACKAGE (69315-163-01) |